Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Vireo Growth Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.62 |
52 Week High | CA$0.95 |
52 Week Low | CA$0.14 |
Beta | 1.37 |
11 Month Change | 5.08% |
3 Month Change | -16.22% |
1 Year Change | 300.00% |
33 Year Change | -70.48% |
5 Year Change | -75.49% |
Change since IPO | -87.60% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost
Jun 01Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 06Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump
Feb 01Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt
Dec 14Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?
Jul 14Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?
Mar 19Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?
Jan 25Vireo Health International's (CSE:VREO) Shareholders Are Down 55% On Their Shares
Sep 04Shareholder Returns
VREO | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 3.3% | -11.5% | -5.8% |
1Y | 300.0% | 26.4% | 6.9% |
Return vs Industry: VREO exceeded the Canadian Pharmaceuticals industry which returned 24.4% over the past year.
Return vs Market: VREO exceeded the Canadian Market which returned 8.2% over the past year.
Price Volatility
VREO volatility | |
---|---|
VREO Average Weekly Movement | 13.5% |
Pharmaceuticals Industry Average Movement | 10.3% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.4% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: VREO's share price has been volatile over the past 3 months.
Volatility Over Time: VREO's weekly volatility has decreased from 19% to 13% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 438 | Josh Rosen | vireohealth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
VREO fundamental statistics | |
---|---|
Market cap | CA$88.25m |
Earnings (TTM) | -CA$23.63m |
Revenue (TTM) | CA$134.79m |
0.7x
P/S Ratio-3.8x
P/E RatioIs VREO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VREO income statement (TTM) | |
---|---|
Revenue | US$98.04m |
Cost of Revenue | US$47.00m |
Gross Profit | US$51.05m |
Other Expenses | US$68.24m |
Earnings | -US$17.19m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.12 |
Gross Margin | 52.07% |
Net Profit Margin | -17.53% |
Debt/Equity Ratio | -320.5% |
How did VREO perform over the long term?
See historical performance and comparison